Pre-Implantation Genetic Testing is done in conjunction with an IVF cycle to ensure only genetically normal embryos will be selected to transfer into the uterus for implantation. With PGT, one or two cells are taken from the embryo on Day 3 or 5 and assessed for chromosomal defects that may lead to miscarriages or genetic disorders. This embryo screening technique has many benefits, including:
• Boost the success rates of pregnancy and live birth with IVF treatment
• Reduce the rate of miscarriage
• Reduce the risk of the embryo inheriting a genetic disease
• Only normal embryos will be transferred to the mother’s womb
There are 2 types of genetic tests which are used to identify genetic flaws in embryos, which are Pre-Implantation Genetic Testing for Aneuploidy (PGT-A) and Pre-Implantation Genetic Testing for Monogenic Diseases (PGT-M).